Petition Piles Pressure On FDA Over Biosimilar Suffix

 
• By Dave Wallace
  
Suffix
Suffixes To Biosimilar Names Are Once Again In The Spotlight • Source: Shutterstock

More from Regulation

More from Policy & Regulation